Sign inGet started

BARBARI SHARON SURREY

Insider CIK 1240499 · CYTK EVP, Finance & CFO · AGRX Director · OCLS Director · MNLO Director · FOMX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
VYNE VYNE Therapeutics Inc. A Award deriv2025-12-122025-12-1520,000— $020,000SEC↗
VYNE VYNE Therapeutics Inc. A Award deriv2024-12-122024-12-1320,000— $020,000SEC↗
AGRX AGILE THERAPEUTICS INC D To issuer2024-08-262024-08-26973$1.52 $1.5K0SEC↗
VYNE VYNE Therapeutics Inc. A Award deriv2024-01-012024-01-0320,000— $020,000SEC↗
VYNE VYNE Therapeutics Inc. A Award deriv2023-12-132023-12-1520,000— $020,000SEC↗
AGRX AGILE THERAPEUTICS INC A Award deriv2023-06-082023-06-091,065— $01,065SEC↗
AGRX AGILE THERAPEUTICS INC A Award2023-06-082023-06-09935— $0974SEC↗
VYNE VYNE Therapeutics Inc. A Award deriv2022-08-102022-08-1220,500— $020,500SEC↗
AGRX AGILE THERAPEUTICS INC A Award deriv2022-06-092022-06-10807— $0807SEC↗
AGRX AGILE THERAPEUTICS INC A Award2022-06-092022-06-10670— $01,952SEC↗
VYNE VYNE Therapeutics Inc. A Award deriv2021-07-192021-07-2020,500— $020,500SEC↗
AGRX AGILE THERAPEUTICS INC A Award deriv2021-06-082021-06-1029,905— $029,905SEC↗
AGRX AGILE THERAPEUTICS INC A Award2021-06-082021-06-1024,510— $051,296SEC↗
MNLO Menlo Therapeutics Inc. M Exercise deriv2020-08-202020-08-2175,000— $013,971SEC↗
MNLO Menlo Therapeutics Inc. M Exercise2020-08-202020-08-2175,000$1.48 $111.0K75,000SEC↗
MNLO Menlo Therapeutics Inc. A Award deriv2020-08-032020-08-0522,500— $022,500SEC↗
AGRX AGILE THERAPEUTICS INC A Award deriv2020-06-092020-06-1145,212— $045,212SEC↗
AGRX AGILE THERAPEUTICS INC A Award2020-06-092020-06-1126,786— $026,786SEC↗
MNLO Menlo Therapeutics Inc. A Award deriv2020-03-192020-03-2345,000— $045,000SEC↗
FOMX Foamix Pharmaceuticals Ltd D To issuer deriv2020-03-092020-03-1149,412— $00SEC↗
MNLO Menlo Therapeutics Inc. A Award deriv2020-03-092020-03-1129,271— $029,271SEC↗
FOMX Foamix Pharmaceuticals Ltd A Award deriv2019-05-162019-05-2049,412— $049,412SEC↗
SNOA Sonoma Pharmaceuticals, In A Award2018-03-012018-03-021,424— $043,417SEC↗
SNOA Sonoma Pharmaceuticals, In A Award2018-01-022018-01-0317,211— $041,993SEC↗
SNOA Sonoma Pharmaceuticals, In A Award2017-11-292017-12-0113,944— $024,782SEC↗
SNOA Sonoma Pharmaceuticals, In A Award2017-08-292017-08-30880— $010,838SEC↗
SNOA Sonoma Pharmaceuticals, In A Award2017-05-302017-06-01754— $09,958SEC↗
SNOA Sonoma Pharmaceuticals, In A Award2017-03-012017-03-02710— $09,204SEC↗
SNOA Sonoma Pharmaceuticals, In A Award2017-02-282017-03-022,250— $08,494SEC↗
CYTK CYTOKINETICS INC A Award2017-02-282017-03-0218,750— $047,640SEC↗
CYTK CYTOKINETICS INC F Tax w/h2017-02-282017-03-027,317$10.60 $77.6K40,323SEC↗
OCLS Oculus Innovative Sciences A Award2016-11-292016-11-301,035— $06,244SEC↗
OCLS Oculus Innovative Sciences A Award2016-08-292016-08-301,199— $05,209SEC↗
OCLS Oculus Innovative Sciences A Award2016-05-312016-06-014,445— $020,051SEC↗
OCLS Oculus Innovative Sciences A Award2016-02-292016-03-024,356— $04,356SEC↗
OCLS Oculus Innovative Sciences A Award2016-02-292016-03-0211,250— $015,606SEC↗
CYTK CYTOKINETICS INC A Award deriv2016-02-232016-02-2574,987— $074,987SEC↗
CYTK CYTOKINETICS INC A Award deriv2016-02-232016-02-2515,013— $015,013SEC↗
OCLS Oculus Innovative Sciences A Award deriv2015-11-302015-12-024,920— $080,968SEC↗
OCLS Oculus Innovative Sciences A Award deriv2015-08-312015-09-025,109— $076,048SEC↗
OCLS Oculus Innovative Sciences A Award deriv2015-06-012015-06-026,972— $070,939SEC↗
OCLS Oculus Innovative Sciences A Award deriv2015-03-022015-03-037,246— $063,967SEC↗
CYTK CYTOKINETICS INC A Award deriv2015-02-262015-03-0262,849— $062,849SEC↗
CYTK CYTOKINETICS INC A Award deriv2015-02-262015-03-0212,151— $012,151SEC↗
OCLS Oculus Innovative Sciences A Award deriv2014-12-012014-12-024,451— $056,721SEC↗
OCLS Oculus Innovative Sciences A Award deriv2014-07-152014-07-162,270— $052,270SEC↗
CYTK CYTOKINETICS INC A Award deriv2014-02-242014-02-2657,260— $057,260SEC↗
CYTK CYTOKINETICS INC A Award deriv2014-02-242014-02-2612,740— $012,740SEC↗
CYTK CYTOKINETICS INC M Exercise deriv2013-09-032013-09-0516,666— $00SEC↗
CYTK CYTOKINETICS INC M Exercise2013-09-032013-09-0516,666— $031,040SEC↗
CYTK CYTOKINETICS INC F Tax w/h2013-09-032013-09-056,262$7.65 $47.9K24,778SEC↗
CYTK CYTOKINETICS INC A Award deriv2013-03-052013-03-07134,728— $0134,728SEC↗
CYTK CYTOKINETICS INC A Award deriv2013-03-052013-03-07165,272— $0165,272SEC↗
CYTK CYTOKINETICS INC M Exercise deriv2012-09-042012-09-05100,000— $0100,000SEC↗
CYTK CYTOKINETICS INC M Exercise2012-09-042012-09-05100,000— $0120,377SEC↗
CYTK CYTOKINETICS INC F Tax w/h2012-09-042012-09-0536,631$0.76 $27.8K83,746SEC↗
CYTK CYTOKINETICS INC A Award deriv2012-03-052012-03-0758,665— $058,665SEC↗
CYTK CYTOKINETICS INC A Award deriv2012-03-052012-03-07116,335— $0116,335SEC↗